Spironolactone Treatment for Dermatologic Conditions is Associated With Blood Pressure Changes in Patients on Concomitant Antihypertensives: A Retrospective Cohort Study
Dr. Lipner has served as a consultant for Veradermics. Dr. Chernoff has served as a consultant for Incyte. The authors declare no conflicts of interest. The data that support the findings of this study are available from the corresponding author upon reasonable request.
Authors
- Shari R. Lipner (ORCID: https://orcid.org/0000-0001-5913-9304)
- Michael Ong (ORCID: https://orcid.org/0000-0002-0347-5541)
- Karen A. Chernoff
- Zachary Neubauer (ORCID: https://orcid.org/0009-0006-4497-2866)
- Ryan Chan (ORCID: https://orcid.org/0009-0000-4083-8682)
Institutions
- Thomas Jefferson University (US)
- New York Medical College (US)
- Cornell University (US)
- Weill Cornell Medicine (US)
Publication Details
- Journal
- International Journal of Dermatology
- Published
- 2026-05-12
- DOI
- https://doi.org/10.1111/ijd.70468
- Primary Topic
- Hormonal Regulation and Hypertension
- Type
- article
- Field-Weighted Citation Impact
- 0.00